Transmucosal fentanyl-related opioid use disorder in a cancer survivor.

Therapie

Service de pharmacologie clinique et pharmacovigilance, centre d'évaluation et d'information sur la pharmacodépendance-addictovigilance (CEIP-A) PACA-Corse, AP-HM Timone, AMU, INS, Inserm UMR1106, 13000 Marseille, France.

Published: February 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.therap.2024.02.002DOI Listing

Publication Analysis

Top Keywords

transmucosal fentanyl-related
4
fentanyl-related opioid
4
opioid disorder
4
disorder cancer
4
cancer survivor
4
transmucosal
1
opioid
1
disorder
1
cancer
1
survivor
1

Similar Publications

In order to characterize fentanyl-related deaths in the province of Ontario, Canada, a retrospective study of all cases in which fentanyl was quantitated in blood was conducted for the time period between 2002 and 2004. A total of 112 fentanyl-related deaths were identified. Decedents ranged in age from 4 to 93 years and comprised 63 men and 49 women.

View Article and Find Full Text PDF

In the last few years great interest has developed in new modes of opioid administration; oral transmucosal, transdermal, peripheral, and nasal administration.Oral transmucosal administration of fentanyl citrate (OTFC) has most often been used for premedication in children. Meanwhile, studies on the use of OTFC in cancer patients for postoperative pain management have also been published.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!